Janssen dual action tablet for prostate cancer gets recommended marketing authorization 13-Mar-2023 By Liza Laws Small molecule drug, Niraparib combined with abiraterone acetate (AA) and prednisone (P) significantly reduces the risk of disease progression, or death, in patients with a type of prostate cancer, a consultant in Spain has said.
